Ignite Creation Date:
2024-05-06 @ 7:08 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05904054
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-16
First Post:
2023-06-02
Brief Title:
Immunogenicity and Safety Study of SARS-CoV-2 DNA Vaccine ICCOV
Sponsor:
Immuno Cure 3 Limited
Organization:
Immuno Cure Holding HK Limited
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-15
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-02
First Submit QC Date:
June 12 2023
Study First Post Date:
2023-06-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-15
Last Update Post Date:
2024-02-16
Last Update Post Date Type:
ACTUAL